Cargando…

Development of new in silico methods to identify ligands for orphan GPCR

Detalles Bibliográficos
Autores principales:	Weill, Nathanael, Rognan, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235238/ http://dx.doi.org/10.1186/1752-153X-2-S1-S17

Ejemplares similares

Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
por: van den Brink, Rinke
Publicado: (2014)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

The HHV-8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells
por: Lira, Sergio A
Publicado: (2006)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
por: Roumen, Luc, et al.
Publicado: (2011)

The Orphan Adhesion-GPCR GPR126 Is Required for Embryonic Development in the Mouse
por: Waller-Evans, Helen, et al.
Publicado: (2010)

Scope and management of Patient Registries for orphan rare disease (ORD) meeting the demands of all involved stakeholders
por: Hernberg-Ståhl, Elizabeth
Publicado: (2010)

Investigation of GPCR allosterism and dimerization in single living cells using fluorescent ligands
por: Hill, Stehen
Publicado: (2015)

Editorial: New approaches for the discovery of GPCR ligands
por: Morales, Paula, et al.
Publicado: (2023)

ALXR, a common GPCR gateway for antiinflammatory and/or proinflammatory cell activation: relevance of selective kinase and phospholipase signaling by uteroglobin, lipoxin A(4 )and serum amyloid A in ALXR-mediated chemotaxis
por: Antico, G, et al.
Publicado: (2004)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

Issues in structure-modifying osteoarthritis drug development: new insights regarding radiographic clinical trial methods
por: Beary, JF, et al.
Publicado: (2004)

In silico prediction of B cell epitopes and experimental validation on wheat allergens
por: Denery-Papini, Sandra, et al.
Publicado: (2014)

Outcome of Manuscripts Rejected From Intensive Care Medicine: An In Silico Study
por: Citerio, G, et al.
Publicado: (2015)

The protein flexibility in receptor-ligand docking simulations
por: Tristram, Frank
Publicado: (2010)

PSMA ligands for diagnosis and therapy of prostate cancer
por: Haberkorn, Uwe
Publicado: (2014)

Structure-guided development of heterodimer-selective GPCR ligands
por: Hübner, Harald, et al.
Publicado: (2016)

Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals
por: Tang, Huihao, et al.
Publicado: (2019)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Prospective study of 393 adolescent thoracic hyperkyphosis patients treated by the Lyon method
por: Claude de Mauroy, Jean, et al.
Publicado: (2013)

P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same
por: Jan, Abiroo
Publicado: (2022)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Variation of geometrical and physicochemical properties in protein binding pockets and their ligands
por: Kahraman, Abdullah, et al.
Publicado: (2007)

Developing new treatments for breast cancer
por: Lane, D
Publicado: (2004)

Two steps forward, one step back: successes and failures in structure-based discovery of GPCR ligands
por: Carlsson, Jens
Publicado: (2015)

Winnow based identification of potent hERG inhibitors in silico: comparative assessment on different datasets
por: Marchese Robinson, Richard L, et al.
Publicado: (2012)

Development of a diagnostic rule for identifying radiographic osteoarthritis in people with first metatarsophalangeal joint pain
por: Zammit, Gerard V, et al.
Publicado: (2011)

pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
por: Velloso, João Paulo L, et al.
Publicado: (2021)

Developing a new brace with pressure measurements
por: Hermus, J, et al.
Publicado: (2009)

The tumor microenvironment: the involvement of the selectin-selectin-ligand axis in tumor-endothelium interactions
por: Witz, Isaac P
Publicado: (2006)

Optimization and antiviral analysis of peptide ligands for the HIV-1 packaging signal PSI
por: Dietz, Julia, et al.
Publicado: (2006)

PPARγ ligands inhibit catabolic and inflammatory responses in articular joint cells
por: Fahmi, H, et al.
Publicado: (2003)

Harnessing cyclotides to design and develop novel peptide GPCR ligands
por: Muratspahić, Edin, et al.
Publicado: (2020)

MOH Drug SCM Strategy Development: a means to identify human resource training needs in Indonesia
por: Sosialina, Engko, et al.
Publicado: (2014)

An in silico study on molecular level interactions of host Siderocalin with siderophores from Mycobacterium tuberculosis and other bacterial species
por: Goyal, Tanu, et al.
Publicado: (2014)

Modeling of nanomaterials: recent applications and new tools development
por: Goldbeck-Wood, G
Publicado: (2008)

Ligand based lead generation - considering chemical accessibility in rescaffolding approaches via BROOD
por: Wang, Li-hsing, et al.
Publicado: (2012)

OA011-05. TLR-mediated pDC responses to HIV-1 ligands
por: Chang, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fovb7jlrpcci29jt5r58fqssol